Patent details

EP1937642 Title: CRYSTALS OF LAQUINIMOD SODIUM, AND PROCESS FOR THE MANUFACTURE THEREOF

Basic Information

Publication number:
EP1937642
PCT Application Number:
PCT/US/2006/040925
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP068262971
PCT Publication Number:
WO/2007/047863
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALS OF LAQUINIMOD SODIUM, AND PROCESS FOR THE MANUFACTURE THEREOF
French Title of Invention:
CRISTAUX DE SODIUM DE LAQUINIMOD, ET PROCEDE DE FABRICATION DE CEUX-CI
German Title of Invention:
KRISTALLE VON LAQUINIMOD-NATRIUM UND VERFAHREN ZU DEREN HERSTELLUNG
SPC Number:

Dates

Filing date:
18/10/2006
Grant date:
10/09/2014
EP Publication Date:
10/09/2014
PCT Publication Date:
26/04/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/07/2008
EP B1 Publication Date:
10/09/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/10/2018
Expiration date:
18/10/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/10/2006
 
 

Name:
Teva Pharmaceutical Industries Ltd
Address:
5 Basel Street PO Box 3190, 49131 Petach Tikva, Israel (IL)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
29/10/2014
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
GUREVICH Eduard
Address:
Israel (IL)

2

Name:
LAXER Avital
Address:
Israel (IL)

3

Name:
FRENKEL Anton
Address:
Israel (IL)

Priority

Priority Number:
728657 P
Priority Date:
19/10/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 215/56;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
19/10/2017
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages
28/02/2019 Outgoing Correspondence 1